Recovery & Repair · Recovery & Repair peptide (research)
PEG-MGF
- Drug class
- Recovery & Repair peptide (research)
- Status
- Compounded (503A)
- Also known as
- mechano growth factor, mgf, pegylated mgf, igf-1ec
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What PEG-MGF is studied for
- Satellite cell activation (research)
- Muscle repair (research)
- Extended half-life (research)
Mechanism of action
PEG-MGF is being studied in the recovery & repair category. PEGylated mechano growth factor studied for satellite cell activation. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is PEG-MGF?
PEG-MGF is a recovery & repair peptide. PEGylated mechano growth factor studied for satellite cell activation.
What is PEG-MGF studied for?
Published research has examined PEG-MGF for satellite cell activation, muscle repair, extended half-life. Human clinical evidence varies by indication.
Is PEG-MGF FDA-approved?
No. PEG-MGF is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is PEG-MGF used in research?
Protocols vary by study. PEG-MGF is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for PEG-MGF is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.